A new study in the peer-reviewed journal Human Gene Therapy showed that more than half of individuals with Niemann-Pick disease, type C1 (NPC1) who were tested lacked neutralizing antibodies ...

Genetic dystonias were previously classified according to a DYT (dystonia) number assigned to each disease locus. This has been revised to reference the gene name rather than the disease locus.